首页> 外文期刊>Journal of Molecular Biology Research >Correlation Between mpMRI Staging and Final Surgical Pathology in Prostate Cancer
【24h】

Correlation Between mpMRI Staging and Final Surgical Pathology in Prostate Cancer

机译:前列腺癌MPMRI分期与最终外科病理学的相关性

获取原文
       

摘要

Purpose: We evaluated the role of multiparametric magnetic resonance imaging (mpMRI) in the diagnosis of prostate cancer and predicting of surgical staging of prostate cancer. Materials and Methods: The study was done in 110 subjects who got mpMRI before radical prostatectomy in our hospital from 2016 to 2019. Preoperative mpMRI findings of 110 were compared to surgical pathology results following radical Prostatectomy. A comparison was made between pathologic staging of prostate cancer and the mpMRI findings. Results: pathologic evaluation confirmed prostate cancer foci (237) were recognized in 110 subjects. Generally, mpMRI sensitivity of 46.4% was found for prostate cancer detection (110/237). Pathological tumor volume was a significant predictor of prostate cancer detection using mpMRI. In 33% of the cases, the pathologic staging is precisely similar to mpMRI and in 43%of the cases, there was a slight difference between the pathologic staging and staging by mpMRI but the cancer was confined to the prostate.in 24% of the cases, there was a significant difference between the pathologic staging and staging by mpMRI. The mpMRI was not able to identify the significant cancer in 24% of the cases. Conclusion: The preoperative mpMRI was useful in detecting prostate cancer and in predicting surgical staging. However, the detection of 24% of clinically significant cancer was missed using mpMRI. As we move toward personalized medicine, use of MRI to biopsy each man's prostate differently rather than based on a pre-defined 12 core seems to be supported in the recent literature.
机译:目的:我们评估了多射磁共振成像(MPMRI)在前列腺癌诊断中的作用及前列腺癌外科手术分期。材料和方法:该研究是在2016年至2019年从我们院内医院的自由基前列腺切除术之前进行的110个受试者进行的。术前MPMRI调查结果与自由基前列腺切除术后的手术病理结果相比。在前列腺癌和MPMRI调查结果的病理分期之间进行了比较。结果:病理评估确认前列腺癌焦点(237)在110名受试者中得到认可。通常,发现前列腺癌检测(110/237)发现46.4%的MPMRI敏感性。病理肿瘤体积是使用MPMRI的前列腺癌检测的显着预测因子。在33%的病例中,病理分期与MPMRI恰好类似,在43%的病例中,PAMRI病理分期和分期之间存在略有差异,但癌症被限制在前列腺上。24%的癌症病例,MPMRI病理分期和分期之间存在显着差异。 MPMRI无法在24%的病例中识别重要癌症。结论:术前MPMRI可用于检测前列腺癌及预测手术分期。然而,使用MPMRI检测24%的临床显着癌症。随着我们走向个性化的药物,使用MRI对活检每个人的前列腺不同而不是基于预定义的12个核心似乎在最近的文献中得到了支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号